Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials.
Saved in:
| Title: | Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials. |
|---|---|
| Authors: | Keystone EC; Department of Rheumatology, University of Toronto, Toronto, ON, Canada., Ahmad HA; Rheumatology, Bristol-Myers Squibb, Princeton, NJ., Yazici Y; Department of Internal Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY., Bergman MJ; Department of Medicine, Drexel University College of Medicine, Philadelphia, PA, USA. |
| Source: | Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2020 Aug 01; Vol. 59 (8), pp. 2090-2098. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1462-0332 |
|---|---|
| DOI: | 10.1093/rheumatology/kez455 |
